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Abstract It is well known that arachidonic acid (AA) acts as an
intratesticular factor regulating luteinizing hormone-mediated
testicular steroidogenesis. The present studies were conducted to
determine the effect of AA on steroidogenic enzymes in rat
Leydig cells. Exogenously added AA significantly inhibited
22(R)-hydroxy-cholesterol-stimulated testosterone production,
which is a clear indication that AA is acting at some point after
cholesterol transport to the inner mitochondrial membrane. AA
failed to block the conversion of 22(R)-hydroxycholesterol to
pregnenolone, indicating that the cytochrome P-450 side-chain
cleavage enzyme complex is not the site of inhibition. The present
results demonstrate that only 17L-hydroxysteroid dehydrogenase
seems to be involved in the AA action, since nearly 60%
inhibition of testosterone production was found when the cells
were incubated with androstenedione. Furthermore, no effect of
AA was found when androstenediol was used as substrate in the
testosterone synthesis, which indicates that 3L-hydroxysteroid
dehydrogenase is not affected by AA. The conversion of AA to its
metabolites is not required for its action on 17L-hydroxysteroid
dehydrogenase and the activation of protein kinase C is not
involved in the inhibitory effect.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Numerous studies suggest that arachidonic acid plays an
important role in the regulation of steroidogenesis. Arachi-
donic acid, which is esteri¢ed in the sn-2 position of mem-
brane phospholipids, is mainly directly released from phos-
pholipids by activation of phospholipases A2 (PLA2). It can
be also produced by activation of: phospholipases C (PLC)
followed by diacylglycerol hydrolysis by diacylglycerol lipase;
phospholipases D (PLD) followed by phosphatidic acid phos-
phohydrolase and diacyl glycerol lipase; and, ¢nally, phos-
pholipases A1 (PLA1) followed by lysophospholipase [1].
Arachidonic acid can be further metabolized via the cyclo-
oxygenase-, lipoxygenase- or cytochrome P-450-dependent
epoxygenase pathways to prostaglandins, leukotrienes and
epoxyeicosatrienoic acids respectively [2]. Fatty acids can act
on signal transduction pathways in a direct and/or indirect
manner. However, several studies clearly show that fatty acids
per se are messenger and modulator molecules mediating cell
responses to extracellular signals [1]. Recent results have
shown that luteinizing hormone (LH) causes a dose- and
time-dependent release of arachidonic acid from Leydig cells
[3] and that arachidonic acid metabolites are involved in LH-
induced steroidogenesis [4^6]. Furthermore, arachidonic acid
itself has been reported to act as an additional intracellular
messenger associated with the hormonal action of LH [3,6,7]
and to have an intermediary role in gonadotropin-releasing
hormone (GnRH)-induced testosterone secretion [8,9].
Previous results from our group have shown that, in rat
Leydig cells, arachidonic acid exerts a dose- and time-depend-
ent biphasic e¡ect on LH- and dibutyryl-cAMP-stimulated
testosterone production [10]. At short periods of incubation
this fatty acid inhibits testosterone synthesis by decreasing
cAMP levels. Recently, we have shown that the e¡ect of
arachidonic acid on steroidogenesis is also beyond cAMP for-
mation [11]. In the present study, we investigate whether
arachidonic acid regulates testosterone production at some
point after cholesterol transport to the inner mitochondrial
membrane. Testosterone biosynthesis from cholesterol in Ley-
dig cells involves the action of four steroidogenic enzymes
(Fig. 1) [12]. Here we have examined the e¡ect of arachidonic
acid treatment on the activity of: cholesterol side-chain cleav-
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Fig. 1. Schematic pathways for the conversion of cholesterol to tes-
tosterone. The enzymes considered in this study are in a box.
CSCC: Cholesterol side-chain cleavage enzyme; 3L-HSD: 3L-hy-
droxysteroid dehydrogenase; 17L-HSD: 17L-hydroxysteroid dehy-
drogenase.
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age (CSCC), 3L-hydroxysteroid dehydrogenase (3L-HSD) and
17L-hydroxysteroid dehydrogenase (17L-HSD) enzymes, in rat
testis Leydig cells.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s minimum medium (DMEM) was ob-
tained from Gibco Ltd. (Middlesex, UK). Collagenase (type I) was
purchased from Worthington Biochemical (Freehold, NJ, USA). Cy-
anoketone and SU-10603 (inhibitors of pregnenolone metabolism)
were obtained from Sterling Research Group Europe (Guildford, Sur-
rey, UK). Arachidonic acid (free acid, sealed ampoule), bovine serum
albumin (essentially fatty acid-free) (BSA-FAF), Percoll, trypsin in-
hibitor (1% sterile-¢ltered solution), pregnenolone, progesterone, an-
drostenediol, androstenedione and 22(R)-hydroxycholesterol were
purchased from Sigma Quimica (Alcobendas, Spain). All other chem-
icals used were of analytical reagent grade.
2.2. Cell isolation and puri¢cation
Leydig cells were obtained from 200^300 g Sprague-Dawley rats.
All animals received care according to the guidelines of the University
Committee of Animal Resources at the University of AlcalaŁ. The
testes were decapsulated and subjected to longitudinal shaking (65
strokes/min) with collagenase (0.5 mg/ml) and trypsin inhibitor (20
Wl/ml) for 40 min at 37‡C. The cells were ¢ltered through 60 Wm nylon
gauze to remove fragments of seminiferous tubules, and subjected to
centrifugal elutriation followed by Percoll density gradient (0^90% v/
v) centrifugation [13]. Leydig cell purity was routinely s 95%, as
determined by 3L-HSD cytochemistry [13]. Viability of the cells was
determined by diaphorase histochemistry [13] and was not a¡ected by
any of the treatments (the viability was s 90%).
2.3. Cell incubation, testosterone and pregnenolone determinations
Puri¢ed Leydig cells were resuspended in DMEM containing 10
mM HEPES pH 7.5 and 0.1% BSA-FAF and plated into 24-well
Costar culture plates at a density of 100 000 cells/well in a ¢nal vol-
ume of 1 ml. The cells were incubated in monolayer for 2 h at 34‡C in
an air incubator in the presence and absence of di¡erent compounds.
22(R)-Hydroxycholesterol was used as substrate instead of cholesterol
because it is more water-soluble. For pregnenolone measurement, the
cells were pre-incubated for 30 min in the presence of 20 WM SU-
10603 and 5 WM cyanoketone as potent inhibitors of pregnenolone
metabolism (more than 95% in adult rats) [14]. The steroids used as
substrates were dissolved in ethanol. The stock solutions were diluted
with incubation medium before addition to the wells. Arachidonic
acid was ¢rst dissolved in ethanol at a concentration of 80 mM and
further diluted in incubation medium before its addition to the cells.
All the manipulations were done under a nitrogen atmosphere. A new
ampoule of arachidonic acid was used in each experiment. The ¢nal
concentration of ethanol was always less than 0.1% (v/v) and did not
alter basal or stimulated steroid release. The reactions were stopped
with perchloric acid (¢nal concentration 0.12 M) and the samples were
stored at 320‡C. The samples were thawed and neutralized with tri-
potassium phosphate (¢nal concentration 0.11 M) before radioimmu-
noassay of testosterone [15] and pregnenolone [16].
All data are expressed as mean þ S.E.M. from at least three experi-
ments, all of them performed in triplicate. Student’s t-test was used
for statistical analysis and di¡erences were considered signi¢cant when
P6 0.05.
3. Results
Arachidonic acid decreased 22(R)-hydroxycholesterol-
stimulated testosterone production (Fig. 2A) and this e¡ect
was dose-dependent (Fig. 2B). The testosterone production
was inhibited by about 60% with 100 WM of arachidonic
acid at all the cholesterol concentrations studied.
The next experiment was designed to investigate the in-
volvement of CSCC enzyme in the arachidonic acid action.
Leydig cells were incubated with increasing concentrations of
cholesterol (up to 20 WM) and SU-10603 (20 WM) and cyano-
ketone (5 WM) as inhibitors of pregnenolone metabolism in
the presence and absence of 100 WM arachidonic acid. The
levels of pregnenolone produced by Leydig cells were similar
both in the presence and in the absence of arachidonic acid
(Fig. 3).
FEBS 19732 26-1-98
Fig. 2. E¡ect of arachidonic acid (AA) on the conversion of 22(R)-
hydroxycholesterol to testosterone. The cells (105 cells/well/ml) were
incubated with: (A) increasing concentrations of 22(R)-hydroxycho-
lesterol in the absence (a) and presence (b) of AA (100 WM), (B)
increasing concentrations of AA and 22(R)-hydroxycholesterol
(1 WM). Testosterone accumulation was measured in the incubation
medium, as described in Section 2. All data points are the mean þ
S.E.M. of six experiments, each performed in triplicate. When
S.E.M. values are not shown, these are smaller than the respective
symbols.
Fig. 3. Lack of e¡ect of arachidonic acid on 22(R)-hydroxycholes-
terol-stimulated pregnenolone production. Leydig cells (105 cells/
well/ml) were incubated with increasing concentrations of 22(R)-
hydroxycholesterol, in the absence (a) and presence (b) of arachi-
donic acid (100 WM). Pregnenolone accumulation was measured in
the incubation medium, as described in Section 2. All data are the
mean þ S.E.M. of six experiments, each performed in triplicate.
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We then investigated the action of arachidonic acid in preg-
nenolone metabolism. First, Leydig cells were incubated with
increasing concentrations of pregnenolone (up to 2.5 WM)
with or without arachidonic acid, and the levels of testoster-
one were measured. In this case, the fatty acid inhibited the
pregnenolone-stimulated testosterone production by about
60% at all pregnenolone concentrations studied (Fig. 4). Sev-
eral experiments were conducted to determine whether arach-
idonic acid a¡ects testosterone production by modi¢cation of
17L-HSD and/or 3L-HSD activity. Incubation of Leydig cells
with androstenediol, as substrate of 3L-HSD, produced a
dose-dependent stimulation of testosterone production and
non-signi¢cant changes were found when the incubations
were performed in the presence of arachidonic acid (100
WM) (Fig. 5). In order to investigate whether arachidonic
acid modulates testosterone production by modi¢cation of
17L-HSD activity, Leydig cells were incubated with increasing
concentrations of androstenedione (up to 10 WM) in the pres-
ence and absence of arachidonic acid (100 WM). As is shown
in Fig. 6A, arachidonic acid inhibited androstenedione-stimu-
lated testosterone production and this e¡ect followed a dose-
dependent pattern (Fig. 6B). The highest percentage of inhib-
ition was found at 100 WM arachidonic acid. To examine if
the inhibition of 17L-HSD activity by arachidonic acid is due
to the fatty acid itself or to its transformation to active me-
tabolites, we added inhibitors of cyclooxygenase (indometha-
cin), lipoxygenase (NDGA) and epoxygenase P-450 (clotrima-
zole) enzymes together with arachidonic acid (Fig. 7). The
levels of testosterone produced by Leydig cells incubated
with androstenedione (1 WM) were inhibited by arachidonic
acid by about 60%. However, when inhibitors of arachidonic
acid metabolism were present, the percentage of inhibition
was signi¢cantly higher.
Finally, the role of protein kinase C (PKC) in arachidonic
acid action was investigated since it has been shown that in
Leydig cells, PKC can be stimulated by arachidonic acid [10].
Activation of PKC using the tumor-promoting phorbol ester
phorbol-12-myristate-13-acetate (PMA) did not modify the
levels of testosterone produced by androstenedione as sug-
gested by the corresponding results : 4.6 þ 1.1, 241.5 þ 35.7,
79.7 þ 24.7, and 237.1 þ 39.8 nM testosterone/105 cells/2 h,
for cells incubated in basal conditions or in the presence of
androstenedione (1 WM) alone and in combination with arach-
idonic acid (100 WM) or PMA (0.3 WM), respectively.
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Fig. 6. E¡ect of arachidonic acid (AA) on the conversion of andros-
tenedione to testosterone. The cells (105 cells/well/ml) were incu-
bated with: (A) increasing concentrations of androstenedione in the
absence (a) and presence (b) of AA (100 WM), (B) increasing con-
centrations of AA and androstenedione (1 WM). Testosterone accu-
mulation was measured in the incubation medium, as described in
Section 2. All data points are the mean þ S.E.M. of six (A) and
four (B) experiments, each performed in triplicate. When S.E.M.
values are not shown, these are smaller than the respective symbols.
Fig. 5. Lack of e¡ect of arachidonic acid (AA) on androstenediol-
stimulated testosterone production. Leydig cells (105 cells/well/ml)
were incubated with increasing concentrations of androstenediol, in
the absence (a) and presence (b) of AA (100 WM). Testosterone
accumulation was measured in the incubation medium, as described
in Section 2. All data are the mean þ S.E.M. of six experiments,
each performed in triplicate. When S.E.M. values are not shown,
these are smaller than the respective symbols.
Fig. 4. E¡ect of arachidonic acid (AA) on the conversion of pregne-
nolone to testosterone. The cells (105 cells/well/ml) were incubated
with increasing concentrations of prenenolone in the absence (a)
and presence (b) of AA (100 WM). Testosterone accumulation was
measured in the incubation medium, as described in Section 2. All
data points are the mean þ S.E.M. of ¢ve experiments, each per-
formed in triplicate. When S.E.M. values are not shown, these are
smaller than the respective symbols.
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4. Discussion
Previous results from our group have indicated that arach-
idonic acid regulates LH-stimulated testosterone production
by decreasing cAMP production. However, this fatty acid
seems to act also at some point below cAMP formation
[11]. The results presented here show that administration of
exogenous arachidonic acid to rat Leydig cells resulted in a
decrease of 22(R)-hydroxycholesterol-stimulated testosterone
production, which is a clear indication that the post-cAMP
e¡ects of this fatty acid are directly concerned, at least in part,
with steroidogenic enzymes. Similar results have been ob-
served in other steroidogenic cells, like granulosa [17] and
theca [18] cells, in which the inhibitory e¡ect of arachidonic
acid on steroidogenesis occurs by decreasing the conversion of
cholesterol to progesterone or androstenedione, respectively.
The ¢rst step in the biosynthesis of testosterone from chol-
esterol is its transport to the inner mitochondrial membrane,
where it is acted upon by CSCC enzyme to produce pregne-
nolone. In our system, arachidonic acid failed to block the
conversion of 22(R)-hydroxycholesterol to pregnenolone, in-
dicating that the cytochrome P-450 side-chain cleavage en-
zyme complex is not the site of inhibition. However, the e¡ect
of arachidonic acid on CSCC enzyme seems to be dependent
on the cell type studied. While in Leydig (present results) and
theca [18] cells this fatty acid has no e¡ect on this rate-limiting
step of steroidogenesis, in granulosa cells arachidonic acid
decreases the ability of cells to convert cholesterol to pregne-
nolone [17].
Because CSCC enzyme was not a¡ected by arachidonic
acid, a decrease of testosterone levels is likely when Leydig
cells are incubated with pregnenolone in the presence of this
fatty acid. In fact, our results indicate that pregnenolone-
stimulated testosterone production is inhibited (about 60%)
by arachidonic acid. Three enzymes are involved in the bio-
synthesis of testosterone from pregnenolone: 3L-HSD, 17K-
hydroxylase/lyase and 17L-HSD [12]. Results from the present
study demonstrate that only 17L-HSD seems to be involved in
the arachidonic acid action, since nearly 60% inhibition of
testosterone production was found when the cells were incu-
bated with androstenedione. Furthermore, no arachidonic
acid e¡ect was found when androstenediol was used as sub-
strate in testosterone synthesis, which is a clear indication that
3L-HSD is not a¡ected by the fatty acid. Similar results have
been obtained in granulosa cells, where the conversion of
pregnenolone to progesterone was not inhibited in the pres-
ence of arachidonic acid [17].
The action of arachidonic acid on signal transduction path-
ways can be achieved directly and/or indirectly by catabolic
conversion to eicosanoids. The inhibitory e¡ect of arachidonic
acid on 17L-HSD was shown to be not dependent on metab-
olism to eicosanoids since cyclooxygenase, epoxygenase and
lipoxygenase inhibitors potentiated this inhibitory e¡ect. In
agreement with this, Romanelli et al. [7] and Lin [9] found
that conversion of arachidonic acid to its metabolites is not
required for its steroidogenic e¡ects in rat Leydig cells. How-
ever, Mele et al. [6] recently stated that the lipoxygenase path-
way is involved in the mechanism of action of LH on testis
Leydig cells and these products seem to be important in the
later conversion of pregnenolone to testosterone [19]. Our
results strongly support the previous concept that the arach-
idonic acid e¡ect on Leydig cells is not due to its transforma-
tion to active metabolites. Furthermore, the presence of inhib-
itors of arachidonic acid metabolism in the incubation
medium together with the fatty acid results in higher inhib-
ition of androstenedione-stimulated testosterone production
than that obtained in the absence of the inhibitors. This fact
can be explained by the blocking e¡ect of indomethacin, clo-
trimazole and NDGA, on the further arachidonic acid metab-
olism, thus increasing its concentration into the cells and
therefore its inhibitory e¡ect.
In a number of studies, phosphorylation has been shown to
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Fig. 7. E¡ect of arachidonic acid (AA) metabolism inhibitors on androstenedione-stimulated testosterone production. The cells (105 cells/well/
ml) were incubated with medium alone (basal) or androstenedione in the absence and presence of AA and its metabolism inhibitors. The data
represent the mean þ S.E.M. of three di¡erent experiments each performed in triplicate. *P6 0.05, **P6 0.01, vs. testosterone production with
androstenedione/AA.
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be involved in regulating enzyme activity, including the NAD-
and NADP-dependent dehydrogenases. Various potential
phosphorylation sites for PKC, casein kinase (CK) and pro-
tein kinase A (PKA) have been detected in recently cloned
17L-HSD isoenzymes [20] and it has been postulated that
multiple kinases may play a role in the regulation of 17L-
HSD [21]. Furthermore, we have previously shown that
arachidonic acid stimulated PKC activity in rat Leydig cells
[10], so it is likely that PKC could mediate the action of
arachidonic acid. However, our results clearly indicate that
PKC activation has no e¡ect on 17L-HSD activity.
The mechanisms of the inhibitory e¡ect of the fatty acid on
17L-HSD remain to be determined, but they seems to be spe-
ci¢c to this enzyme. It has been postulated that in the rat
testis, the enzymes of androgen biosynthesis, associated with
the smooth endoplasmic reticulum, have speci¢c requirements
for optimal activity such as the membrane lipid composition
[22]. Alterations of the structure of the membrane environ-
ment produced by arachidonic acid could be responsible for
the inhibition of 17L-HSD. In agreement with this, Cooke and
Robaire [23] demonstrated that steroid biosynthetic enzymes
di¡er in their requirements with respect to the polar and non-
polar regions of the membrane and that changes in the mem-
brane environment can regulate the activity of steroidogenic
enzymes. In our system, 17L-HSD appears to be sensitive to
changes in the structure of the membrane environment.
In conclusion, the present results demonstrate that 17L-
HSD activity is under arachidonic acid control and support
the idea that this fatty acid acts as an additional intracellular
messenger associated with the hormonal action of LH.
Acknowledgements: We are grateful to Dr. B.A. Cooke (Royal Free
Hospital, School of Medicine, London, UK) for the gift of testoster-
one and pregnenolone antibodies. This work was supported in part by
a Grant (PB94-360) from the DireccioŁn General de InvestigacioŁn
Cient|Ł¢ca y TeŁcnica and by the University of AlcalaŁ.
References
[1] Graber, R., Sumida, C. and Nunez, E.A. (1994) J. Lipid Mediat.
Cell Signal. 9, 91^116.
[2] Needleman, P., Turk, J., Jaschik, B.A., Morrison, A.R. and Lef-
kowitz, J.B. (1986) Annu. Rev. Biochem. 55, 69^102.
[3] Moraga, P.F., Llanos, M.N. and Ronco, A.M. (1997) J. Endo-
crinol. 154, 201^209.
[4] Dix, C.J., Habber¢eld, A.D., Sullivan, M.H.F. and Cooke, B.A.
(1984) Biochem. J. 219, 529^537.
[5] Didolkar, A.K. and Sundaram, K. (1987) Life Sci. 41, 471^477.
[6] Mele, P.G., Dada, L.A., Paz, C., Neuman, I., Cymeryng, C.B.,
Mendez, C.F., Finkielstein, C.V., Maciel, F.C. and Podesta, E.J.
(1997) Endocr. Res. 23, 15^26.
[7] Romanelli, F., Valenca, M., Conte, D., Isidori, A. and Negro-
Vilar, A. (1995) J. Endocrinol. Invest. 18, 186^193.
[8] Didolkar, A.K. and Sundaram, K. (1989) J. Androl. 10, 449^455.
[9] Lin, T. (1985) Life Sci. 36, 1255^1264.
[10] LoŁpez-Ruiz, M.P., Choi, M.S.K., Rose, M.P., West, A.P. and
Cooke, B.A. (1992) Endocrinology 130, 1122^1130.
[11] Marinero, M.J., ColaŁs, B., Prieto, J.C. and LopeŁz-Ruiz, M.P.
(1996) Mol. Cell. Endocrinol. 118, 193^200.
[12] Stocco, D.M. and Clark, B.J. (1996) Endocr. Rev. 17, 221^244.
[13] Dirami, G., Poulter, L.W. and Cooke, B.A. (1991) J. Endocrinol.
130, 357^365.
[14] Van Haren, L., Cailleau, J. and Rommerts, F.F.G. (1989) Mol.
Cell. Endocrinol. 5, 157^164.
[15] Verjans, H.L., Cooke, B.A., de Jong, F.H., de Jong, C.M.M. and
Van der Molen, H.J. (1973) J. Steroid Biochem. 4, 665^676.
[16] Van der Vusse, G.J., Kalkman, M.L., Van Winsen, M.P.I. and
Van der Molen, H.J. (1975) Biochim. Biophys. Acta 380, 473^
485.
[17] Johnson, A.L. and Tilly, J.L. (1990) Biol. Reprod. 42, 458^464.
[18] Johnson, A.L., Tilly, J.L. and Levorse, J.M. (1991) Biol. Reprod.
4, 338^344.
[19] Reddy, G.P., Prasad, M., Sailesh, S., Kiran Kumar, Y.V. and
Reddanna, P. (1993) Int. J. Androl. 16, 227^233.
[20] Penning, T.M. (1997) Endocr. Rev. 18, 281^305.
[21] Khanum, A., Buczko, E. and Dufau, M.L. (1997) Endocrinology
138, 1612^1620.
[22] Dufau, M.L., Miyagawa, Y., Takada, S., Khanum, A., Miyaga-
wa, H. and Buczko, E. (1997) In: Steroids (2nd Int. Symp. Mo-
lecular Steroidogenesis), Vol. 62, pp. 128^132, Elsevier, New
York.
[23] Cooke, G.M. and Robaire, B. (1988) Biol. Reprod. 39, 329^339.
FEBS 19732 26-1-98
M.J. Marinero et al./FEBS Letters 422 (1998) 10^1414
